Table 2.
Participant characteristics.
| Variable | Intervention (n = 16) |
Waitlist (n = 13) |
Community (n = 16) |
|||
|---|---|---|---|---|---|---|
| M (SD) | Range | M (SD) | Range | M (SD) | Range | |
| Age (years) | 50.4 (8.8) | 37–65 | 51.8 (9.4) | 40–72 | 52.9 (17.0) | 27–77 |
| Education (years) | 15.8 (4.0) | 11–26 | 13.8 (3.5) | 9–20 | 13.9 (3.8) | 10–20 |
| Time since cancer diagnosis (months) | 46.1 (22.8) | 15–87 | 69.2 (56.5) | 14–189 | – | – |
| Time since finished cancer treatment (months) | 37.1 (24.6) | 6–84 | 46.5 (46.1) | 6–137 | – | – |
| % | % | % | ||||
| Living with partner | 68.8 | 84.6 | 75.0 | |||
| Female | 93.8 | 100.0 | 93.8 | |||
| Born in Australia | 62.5 | 76.9 | 56.3 | |||
| Neurological history | 0.0 | 6.3 | 0.0 | |||
| Cancer type | ||||||
| Breast | 75.0 | 76.9 | – | |||
| Hematological | 6.3 | 15.4 | – | |||
| Colorectal | 6.3 | 7.7 | – | |||
| Prostate | 6.3 | – | – | |||
| Ovarian | 6.3 | – | – | |||
| Previous treatment | ||||||
| Chemotherapy | 81.3 | 100.0 | – | |||
| Radiotherapy | 81.3 | 84.6 | – | |||
| Surgery | 87.5 | 84.6 | – | |||
| Other | 81.3 | 69.2 | – | |||
| Hormone treatment (current) | 68.8 | 69.2 | – | |||